News Pfizer's Arena buyout looks canny, as etrasimod aces phase 3... Pfizer placed a $6.7 billion bet on the outcome of two phase 3 trials of Arena Pharmaceu
News Flush with COVID cash, Pfizer tables $6.7bn bid for Arena Pfizer has found another use for the windfall profits it is making from it BioNTech-partnered COVID-19 vaccine, agreeing to buy Arena Pharma and its late-stage ulcerative colitis drug etras
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.